NCT03786003Recruiting
ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007)
Lobectomy for Clincial Stage T1N0M0 Solid NSCLC by VATS Versus Thoracotomy
Source: ClinicalTrials.gov · Last updated 21 Jul 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1007). The goal of this study is to determine video-assisted thoracoscopic surgery is non-inferior to thoracotomy in terms of disease-free survival for solid clinical stage T1N0M0 NSCLC.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1086 (estimated)
- First submitted
- 19 Dec 2018
- Start date
- 9 Feb 2022
- Primary completion date
- 9 Feb 2025
- Lead sponsor
- Fudan University
- Diseases
- Lung cancer
- NCT number
- NCT03786003
What you commit to
- Study type: Interventional
- Planned participants: 1086
- From 9 Feb 2022 to the primary completion date, 9 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not lobectomy or sublobar resection.
- Previous radiation or chemotherapy.
Other illness
- History of other malignant tumors within 5 years.
- History of thoracic surgery or unsuitable for VATS.
Other
- Not NSCLC in pathological analysis.
Who the study is looking for
- Clinical stage T1N0M0 and surgical resectable.
- Solid appearance on computed tomography scan.
- Age 18 to 75 year.
- Signed the informed consent form.
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.